FDA Orange Book · active-ingredient family
Vorinostat
Vorinostat is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ZOLINZA · NDA 021991
1
Brand (NDA)
0
Generics (ANDA)
3
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ZOLINZARLD | MSD SUB MERCK | NDA 021991 | — | Oct 06, 2006 |
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8093295 | May 16, 2026 | 1 mo ago | Product |
| 7456219 | Mar 11, 2027 | in 9 mo | Substance |
| 8450372 | Mar 18, 2028 | in 1 yr 9 mo | U-892 |
Vorinostat — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
